HOUSTON (AP) — HOUSTON (AP) — Cerenome, Inc. (CNSY) on Friday reported a loss of $8.7 million in its third quarter. The Houston-based company said it had a loss of $1.14 per share. The developer of cell therapies posted revenue of $722,000 in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using...